STOCK TITAN

Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure

(Moderate)
(Neutral)
Tags

Diginex (Nasdaq:DGNX) is expanding its end-to-end supply chain due diligence suite with Risk-to-Remedy, integrating LUMEN risk assessment, APPRISE worker engagement and expertise from The Remedy Project. The solution focuses on worker-level evidence, prioritized remediation and regulator-ready reporting amid accelerating global forced-labour and modern slavery regulations.

Loading...
Loading translation...

Positive

  • Launch of Risk-to-Remedy end-to-end supply chain due diligence solution
  • Integration of LUMEN, APPRISE and The Remedy Project’s remediation expertise
  • Targets human rights and supply chain due diligence market projected at $9.6B by 2034
  • Upcoming features to streamline audits, evidence collection and non-compliance tracking
  • Focus on regulator-ready, defensible reporting to support clients under tightening regulations

Negative

  • None.

News Market Reaction – DGNX

-5.45%
5 alerts
-5.45% Session close to close
+3.8% Peak Tracked
-2.9% Trough Tracked
$32.01M Market Cap
0.3x Rel. Volume

In the Jun 4 session, DGNX declined 5.45%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.8% during that session. Argus tracked a trough of -2.9% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.5% in the session following this news. A negative reaction despite a broader prod...
Analysis

The stock moved -5.5% in the session following this news. A negative reaction despite a broader product expansion fits a pattern where DGNX has often sold off on otherwise constructive strategic headlines. The market has previously responded skeptically to large all-share acquisition plans and capital structure changes, which may weigh on sentiment around new initiatives. While the Risk-to-Remedy integration strengthens its ESG and human rights offering, past trading around similar updates shows that execution risk and deal uncertainty have remained key concerns.

Key Figures

Due diligence market 2025: $3.8 billion Due diligence market 2034: $9.6 billion Forced labour share: 86% +1 more
4 metrics
Due diligence market 2025 $3.8 billion Human rights and supply chain due diligence market size in 2025
Due diligence market 2034 $9.6 billion Projected human rights and supply chain due diligence market by 2034
Forced labour share 86% Portion of forced labour occurring in the private sector
People in modern slavery 50 million Estimated number of people globally affected by modern slavery

Historical Context

5 past events · Latest: Jun 03 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 03 Acquisition update Positive -6.0% Update on proposed Resulticks acquisition and extended long stop date.
May 28 ESG data product Positive +10.8% Matter unit triples carbon data automation to 80% for ESG clients.
May 15 Strategy update Positive +1.6% Progress on 16‑month transformation into AI, data and sustainability platform.
May 14 Expansion strategy Positive -20.8% Details on billion‑dollar Resulticks deal and US$100m of acquisitions.
May 07 Investor interview Positive -7.0% Deputy Chairman outlines strategic reset and integrated AI-driven platform.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent strategic and M&A updates have often been met with volatile and sometimes negative reactions, even when the news itself was constructive, indicating a pattern of skepticism or profit taking around positive headlines.

Recent Company History

Over the past few months, DGNX has focused on a transformation into an integrated AI, data and sustainability platform, anchored by a proposed US$1.5 billion all‑share acquisition of Resulticks and over US$100 million in prior M&A. Updates on the Resulticks deal and platform strategy have produced mixed price reactions, with both strong gains and sharp selloffs around news. Today’s supply chain product expansion builds on earlier moves such as the Matter automation breakthrough and The Remedy Project acquisition, extending Diginex’s ESG and human rights toolset.

Key Terms

supply chain due diligence, grievance mechanisms
2 terms
supply chain due diligence technical
"Diginex’s Risk-to-Remedy is an end-to-end solution supporting supply chain transparency..."
Supply chain due diligence is the process companies use to investigate and monitor their suppliers, manufacturers and logistics partners to spot risks such as unsafe labor, environmental harm, fraud or delivery breakdowns. Like inspecting the plumbing before buying a house, it helps investors assess whether a business can reliably make and deliver products, avoid legal or reputational costs, and forecast disruptions or extra expenses that would affect revenue and valuation.
grievance mechanisms regulatory
"strengthened by the acquisition of The Remedy Project’s expertise in grievance mechanisms and remediation"
A grievance mechanism is a formal process a company provides for workers, customers, local communities or suppliers to report harms, complaints or rule violations and seek investigation or remedy. It matters to investors because effective mechanisms act like a safety valve—catching and fixing small problems before they escalate into costly lawsuits, supply disruptions or reputation damage—and they signal better management, transparency and lower long‑term risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

• In a human rights and supply chain due diligence market valued at approximately $3.8 billion in 2025, non-compliance carries material, financial and reputational consequences.

• Diginex’s Risk-to-Remedy is an end-to-end solution supporting supply chain transparency and risk surfacing to enable faster, evidence-based action and more defensible reporting.

• Upcoming enhancements to Diginex’s supply chain offering will enable businesses to make smarter decisions, take effective action and measure outcomes.

LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX), a provider of ESG, sustainability and compliance solutions to institutional and corporate clients, today announced the integration of Risk-to-Remedy as an end-to-end supply chain due diligence solution and introduces the next phase of its supply chain offering.

Built on LUMEN for supply chain risk assessment and APPRISE for direct worker engagement, and strengthened by the acquisition of The Remedy Project’s expertise in grievance mechanisms and remediation, Risk-to-Remedy integrates worker-level evidence, prioritised remediation and regulator-ready reporting within a single framework, closing the gap between what companies declare and what they can demonstrate.

The Regulatory Imperative

With 86% of forced labour occurring in the private sector, and modern slavery affecting an estimated 50 million people globally, most compliance tools still rely on supplier declarations and annual audits that fail to capture workers’ lived experience, leaving a persistent gap between what companies declare and what is actually occurring.

Transparency regimes, including the UK Modern Slavery Act, Australia's Modern Slavery Act, Canada's Fighting Against Forced Labour Act, now sit alongside enforceable due diligence and import-control frameworks including the CSDDD, the German Supply Chain Due Diligence Act, and the EU Forced Labour Regulation. Together, they require organizations to identify, assess, mitigate and remediate labour exploitation with defensible evidence. 

The market reflects this urgency

The human rights and supply chain due diligence market is valued at approximately $3.8 billion in 2025 and is projected to reach $9.6 billion by 2034, driven by tighter regulation, increased investor scrutiny and growing demand for responsible sourcing.

For businesses, the financial case is equally compelling: companies that cannot demonstrate adequate due diligence risk product bans and market exclusion, regulatory fines, costly supplier transitions, and reputational damage, compounding losses that typically far exceed the cost of prevention.

Upcoming enhancements

As part of a larger project to expand its supply chain offering, Diginex will introduce further product features. Alongside current risk functionality, the new capabilities will enable clients to manage assessments and audits more efficiently, collect and organize supporting evidence more effectively, monitor non-compliance and corrective actions with greater discipline, and maintain clearer, regulator-ready records of decision-making and follow-through.

As supply chain due diligence becomes a strategic priority, organizations require solutions that can deliver both depth and scale. Diginex is well positioned to support this shift combining technology-led efficiency with the transparency needed to build resilient, responsible supply chains.

About Diginex

Diginex Limited (Nasdaq: DGNX; ISIN KYG286871044), headquartered in London, is a sustainable RegTech business that empowers businesses and governments to streamline ESG, climate, and supply chain data collection and reporting.

The Company utilizes blockchain, AI, machine learning and data analysis technology to increase transparency in corporate regulatory reporting and sustainable finance.

The award-winning diginexESG platform supports multiple global frameworks, including GRI, SASB, and TCFD. Clients benefit from end-to-end support ranging from materiality assessments and data management to stakeholder engagement, report generation, and ESG Ratings Support Services.

For more information, please visit the Company’s website: www.diginex.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequently occurring events or circumstances, or changes in its expectations, except as may be required by law.

Although the Company believes that the expectations expressed in these forward looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results disclosed in the Company's filings with the SEC.

Investor Relations Contacts

Diginex 
Investor Relations
Email: ir@diginex.com

IR Contact – Europe 
Jan Hutterer
Kirchhoff Consult
Phone: +49 (40) 609186-0
Email: diginex@kirchhoff.de

IR Contact – US 
Jackson Lin
LLYC
Phone: +1 (646) 717-4593
Email: jian.lin@llyc.global


FAQ

What is Diginex (Nasdaq:DGNX) Risk-to-Remedy supply chain due diligence solution?

Risk-to-Remedy is Diginex’s end-to-end supply chain due diligence solution integrating risk assessment, worker engagement and remediation. According to Diginex, it combines LUMEN, APPRISE and The Remedy Project’s grievance and remediation expertise to provide worker-level evidence, prioritized remediation and regulator-ready reporting in a single framework.

How does Diginex (DGNX) integrate LUMEN and APPRISE in its supply chain platform?

Diginex uses LUMEN for supply chain risk assessment and APPRISE for direct worker engagement within Risk-to-Remedy. According to Diginex, this integration enables surfacing worker-level risks, supporting faster, evidence-based action and closing the gap between corporate declarations and demonstrable conditions in global supply chains.

What market opportunity does Diginex (DGNX) target in human rights and supply chain due diligence?

Diginex targets a human rights and supply chain due diligence market valued at about $3.8B in 2025. According to Diginex, this market is projected to reach $9.6B by 2034, driven by tighter regulation, investor scrutiny and increased demand for responsible sourcing solutions.

How will upcoming enhancements to Diginex (DGNX) supply chain offering support compliance?

Planned enhancements will help clients manage assessments and audits more efficiently and organize evidence more effectively. According to Diginex, new features will improve monitoring of non-compliance, corrective actions and decision-making records, supporting clearer, regulator-ready reporting as supply chain due diligence becomes a strategic priority.

Which regulations are driving demand for Diginex (DGNX) supply chain due diligence tools?

Demand is driven by transparency and due diligence regimes addressing forced labour and modern slavery worldwide. According to Diginex, key frameworks include the UK and Australia Modern Slavery Acts, Canada’s Fighting Against Forced Labour Act, CSDDD, Germany’s Supply Chain Due Diligence Act and the EU Forced Labour Regulation.